ArticleCureus2025
A Case of a Hemodialysis Patient With Myelodysplastic Neoplasm-Like Anemia Due to Hypozincemia Treatment.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 50-year-old woman had been on maintenance hemodialysis and used an erythropoiesis-stimulating agent for renal anemia. She developed anemia of unknown cause, and hypozincemia was observed; zinc acetate hydrate was started. However, the improvement was temporary. Leukopenia and macrocytic anemia were observed since the same period, and bone marrow examination revealed abnormal blood cell morphology resembling that of a myelodysplastic neoplasm. She also showed significant hypocopperemia, and we suspected a hematopoietic disorder due to copper deficiency. Zinc acetate hydrate was discontinued, and copper replacement therapy was started. After three weeks, anemia and hypocopperemia improved. Zinc supplementation is sometimes given to hemodialysis patients, but it is important to measure blood copper regularly as zinc supplementation can cause hypocopperemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.